SCHEMBL1815547

SCHEMBL1815547

Cc1cccc(C(=O)O)c1Nc1c(Br)c(C)nn1-c1c(C)cccc1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.42
POLB P06746 1/20 0.39
ADORA1 P30542 4/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MAPT P10636 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
DHODH Q02127 1/20 0.36
RORC P51449 1/20 0.36
HDAC9 Q9UKV0 1/20 0.36
WNT3A P56704 1/20 0.36
ACLY P53396 1/20 0.36
CYP3A4 P08684 2/20 0.35
CYP2C9 P11712 2/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
AKR1B10 O60218 1/20 0.35
TRPA1 O75762 1/20 0.35
ABCB11 O95342 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1818962 0.88 ADORA1 (0.42) KDM4EPOLBADORA1ALDH1A1HPGD
SCHEMBL1817101 0.86 SMN1; SMN2 (0.47) KDM4EPOLBALDH1A1HPGDHSD17B10
SCHEMBL1814786 0.85 KDM4E (0.42) KDM4EADORA1ALDH1A1MAPTRORC
SCHEMBL1810125 0.85 KDM4E (0.42) KDM4EPOLBADORA1DHODHRORC
SCHEMBL1817001 0.85 ADORA1 (0.48) POLBADORA1ALDH1A1CYP3A4CYP2C9
SCHEMBL1811983 0.84 ADORA1 (0.44) KDM4EPOLBADORA1RORCHDAC9
SCHEMBL1809503 0.81 ADORA1 (0.43) KDM4EPOLBADORA1ALDH1A1HPGD
SCHEMBL1814347 0.81 TAS2R14 (0.45) POLBADORA1DHODHTSHR
SCHEMBL1815545 0.81 KDM4E (0.41) KDM4EPOLBADORA1ALDH1A1HPGD
SCHEMBL1811819 0.78 KMT2A (0.46) KDM4EPOLBALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2321296-A1 SUBSTITUTED 5-AMINOPYRAZOLES AND USE THEREOF Bayer Schering Pharma Aktiengesellschaft (DE) 2011-05-18 EP disclosed
US-20100099681-A1 SUBSTITUTED 5-AMINOPYRAZOLES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-04-22 US disclosed
WO-2010020363-A1 SUBSTITUTED 5-AMINOPYRAZOLES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-02-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100099681-A1 SUBSTITUTED 5-AMINOPYRAZOLES AND USE THEREOF CYP3A5, ABAT, TPMT KDM4E 2516/4885POLB 2263/4885ADORA1 724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.